March 12, 2012

Direct Relief USA Offer of Lo Seasonique

We would like to inform you of the program Direct Relief - offering members Lo Seasonique birth control pills at no cost.

Direct Relief USA offer of Lo Seasonique:

Direct Relief USA, through a donation from TEVA Pharmaceuticals, is working with to provide safety net providers with women’s health products for their uninsured, low-income patients.  Through this program, community clinics, free clinics, and health centers can obtain LoSeasonique birth control pills for their patients without health insurance at no cost.

Direct Relief works with safety net clinics throughout the U.S. that provide care to uninsured patients regardless of their ability to pay.  In 2011, shipments containing medications, medical products and supplies - valued at over $53 million (wholesale) - were sent to 1,102 partners across the U.S. Shipments are sent courtesy of FedEx so partners do not incur any expenses associated with participating in Direct Relief’s programs.  Direct Relief is VAWD accredited and is the only non-profit licensed to distribute medications in all 50 states.  

 

HOW TO PARTICIPATE

Are you already a member of the Direct Relief Network?

To request LoSeasonique, please visit the Direct Relief Network. You will need your Direct Relief Network User ID and Password. If you need help logging in, please contact usaprograms@directrelief.org or call 1-877-30-DR-USA.

Do you want to become a member of the Direct Relief Network?

Your clinic or health center may already be a member, please check with your staff to see if your facility already has an account with Direct Relief.

By partnering with Direct Relief USA, your clinic/health center will be eligible to request LoSeasonique and will receive notifications of product offers available through Direct Relief’s Safety Net Support program. To become a partner, please visit the Direct Relief Networkand click on “Healthcare Providers.”

If you have any questions, contact us at usaprograms@directrelief.org or call 1-877-30-DR-USA.

March 12, 2012 in Coupons , Oral Contraceptives , Women’s Health | Permalink | TrackBack (0)

January 17, 2012

An Important Drug Recall - LO/OVRAL-28 and Norgestrel 0.3mg/Ethinyl Estradiol 0.03mg Tablets

Following is a Pfizer generated document we received on Friday, January 13, 2012:

 

Pfizer Inc. is recalling multiple lots of LO/OVRAL - 28 Tablets and Norgestrel 0.3mg/Ethinyl Estradiol 0.03mgTablets manufactured and packaged by Pfizer, and distributed and commercialized by Akrimax Pharmaceuticals, LLC (see below for lot numbers and expiration dates).  Please note that these products are labeled with Akrimax labeling.  Pfizer Inc. voluntarily initiated this recall when it was determined that some blister packs may contain an inexact count of placebo or active ingredient tablets.  Please note that use of this product is not likely to cause adverse health consequences.

 

FEDERAL REGULATIONS REQUIRE THAT YOU RESPOND TO THIS RECALL, EVEN IF YOU DO NOT HAVE THE RECALLED PRODUCT. TO RESPOND, PLEASE CONTACT STERICYCLE INC. AT 1(800)-805-3093 WITHIN FIVE (5) BUSINESS DAYS.

 

The recall of LO/OVRAL - 28 Tablets and Norgestrel 0.3mg/Ethinyl Estradiol 0.03 mg Tablets is being conducted to the retail level.

 

Records indicate that you may have received shipment of affected lots between January 2011 and December 2011.  Please check your stock immediately against the table below.  If you have any of the affected products in your inventory, please stop distribution and promptly return to Stericycle Inc. 2670 Executive Drive, Suite A Indianapolis, IN 46241: Attn: Event 2568.  Please contact Stericycle Inc. at (800) 805-3093 if you require the pre-paid UPS labels.  If you have any medical inquiries regarding these products, please contact Akrimax Medical Information at 1(877)509-3935 (8 AM to 7 PM Mon-Fri CST).

 

If you have further distributed the lots to the retail level, please conduct a sub-recall and communicate this recall information to those accounts immediately.  Please request that they immediately cease distribution of the affected lots and promptly return the product directly to the above address.  If they have inventory of the affected product, they can contact Stericycle Inc. at (800) 805-3093 to obtain pre-paid shipping labels for product return.  Further authorization is not required for product return.  Reimbursement for the returned product will be made by credit memorandum.  If you have any questions regarding the reimbursement, please contact your Akrimax Customer Service Representative at 1(877) 509-3935 (8 AM to 7 PM Mon-Fri CST).

 

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.  We appreciate your immediate attention and cooperation to this matter.

 

LO/OVRAL® - 28 

LOT#         Expiration Date

E15678        8/31/2013

E15679        8/31/2013

E15686        8/31/2013

   E15687        1/31/2014   

E15690        1/31/2014

E15698        1/31/2014

E15700        2/28/2014

E80434        7/31/2013

E80438        8/31/2013

F36908        2/28/2014

F36909        2/28/2014

F43915        3/31/2014

F43926        3/31/2014

F43927        3/31/2014

 

NORGESTREL 0.3MG/ETHINYL ESTRADIOL 0.03 MG

LOT#         Expiration Date

E15677        8/31/2013

E15704        1/31/2014

E15706        1/31/2014

E80440        8/31/2013

F16388        1/31/2014

F16390        2/28/2014

F22132        2/28/2014

F31330        2/28/2014

F36911        3/31/2014

F36913        3/31/2014

F43924        3/31/2014

F43925        3/31/2014

F43934        3/31/2014

F53238        3/31/2014

January 17, 2012 in Contraception , Cooperative Updates , Health Care , Oral Contraceptives , Pharmaceutical Products , Pharmaceuticals , Sales , Women’s Health | Permalink | TrackBack (0)

October 19, 2011

Daily-Vite from R&S Northeast

Daily-Vite from R&S Northeast

Daily Multiple Vitamin Supplement

 

Save 10% off your first purchase of 12 Bottles of Daily-Vites.

Folic Acid is a B vitamin that helps a baby's neural tube grow healthy during pregnancy.  The neural tube will become a baby's brain and spinal cord.  But if the neural tube doesn't close the way it should, it can cause a very serious birth defect called a neural tube defect (NTD).

 

• Folic Acid helps prevent certain brain defects.
• Folic acid works if taken before and during early pregnancy.
• Take a daily multivitamin with 400 micrograms of folic acid.

 

 

Please contact your R&S Sales Representative  for pricing.

Pennsylvania (800) 262-7770

Ohio (866) 994-7472

Kentucky (866) 228-9758

 

Be sure to mention that you are a member of the Cooperative Purchasing Program!

October 19, 2011 in Coupons , Health Care , Pharmaceutical Products , Pharmaceuticals , R&S Northeast , Sales , Teen Pregnancy , Vendors , Women’s Health | Permalink | TrackBack (0)

June 09, 2011

Special Promotion from GYN Disposables

Right now, GYN Disposables is offering Co-Op Members a special offer

Buy 5 UltraLite Kits, Get 1 FREE!

Call 888.377.2203 or visit www.gyndisposables.com

 

June 9, 2011 in Cancer , Cooperative Updates , Coupons , Health Care , Sales , Vendors , Women’s Health | Permalink | TrackBack (0)

June 03, 2009

Review of Studies of IUD Use in Adolescents Finds Favorable Results, Limited Body of Research

Public Release Date: 28-May-2009

Summary of "Intrauterine Devices for Adolescents: a Systematic Review," Deans/Grimes, Contraception, June 2009.

Adolescent pregnancy persists as a "stubborn" public health problem in the U.S., with teenagers accounting for nearly 750,000 pregnancies annually, about 82% of which are unintended. Although adolescents have higher continuation rates with longer-acting contraceptive methods, the majority of them use oral contraceptives and condoms. Adolescents' compliance with shorter-acting methods is mediocre, and many could benefit from methods that are simpler to use and longer-lasting, according to the researchers.

Continue reading "Review of Studies of IUD Use in Adolescents Finds Favorable Results, Limited Body of Research"

June 3, 2009 in Contraception , Contraceptives , Pharmaceuticals , Teen Pregnancy , Women’s Health | Permalink | TrackBack (0)

April 13, 2009

Family Planning Services Exemplify Prevention-Based Health Reform Principles, Guttmacher Policy Review Says

Public Release Date: 26-March-2009

Summary of "Family Planning and Health Care Reform: The Benefits and Challenges of Prioritizing Prevention," Gold, Guttmacher Policy Review, Winter 2009.

President Obama's administration and Congress have indicated an interest in pursuing health care reform that prioritizes prevention, and "family planning exemplifies both the benefits of prevention and the issues inherent in trying to remake the current health financing system to work for prevention," Rachel Benson Gold of the Guttmacher Institute writes in a Guttmacher Policy Review article.

Continue reading "Family Planning Services Exemplify Prevention-Based Health Reform Principles, Guttmacher Policy Review Says "

April 13, 2009 in Health Care , Medical Access , Public Policy , Women’s Health | Permalink | TrackBack (0)

December 09, 2008

Washington Post Magazine Examines Medical Students' Decision Whether To Become Abortion Providers

Public Release Date: 24-November-2008

The Washington Post Magazine on Sunday examined challenges medical students face when considering whether to become abortion providers. According to the Post Magazine, the number of abortion providers in the U.S. is declining, and "unless a new generation [takes] their place, the right to abortion might be rendered meaningless." The Post Magazine profiled Lesley Wojcik -- a medical student at the University of Maryland School of Medicine -- who was considering becoming an abortion provider but ultimately decided to forgo her plans.

Continue reading "Washington Post Magazine Examines Medical Students' Decision Whether To Become Abortion Providers"

December 9, 2008 in Abortion , Health Care , Women’s Health | Permalink | TrackBack (0)

May 22, 2008

For Clinicians: Updated Sexually Transmitted Infection Screening and Treatment

Public Release Date: 14-May-2008

Sexually transmitted infections (STIs) have been in the news recently as new epidemiologic trends emerge:

• Certain strains of gonorrhea are showing resistance to traditional antibiotics.
• Syphilis rates are increasing and disproportionately affect African Americans and men who have sex with men.
• At least one in four teens have an STI.

CFHC has collaborated with staff at the California STD Branch at the California Department of Public Health to highlight important strategies for preventing and treating STIs as recommended by the CDC in their STD Treatment Guidelines.

Recommendations for HPV vaccination and changes in the management of abnormal Pap tests are also noted. Providers are invited to download the 2-page California STD Treatment Summary Table (PDF) and refer to the California STD Clinical Guidelines for further information on the latest recommendations for screening, testing, treatment, and partner management for STIs in California.

click here to continue

Written by: Ina Park M.D., M.S., Clinical STD Fellow, California Department of Public Health-STD Control Branch

Posted thanks to News & Views, a quarterly publication of the California Family Health Council, Inc.

May 22, 2008 in Health Care , Public Policy , STD , Women’s Health | Permalink | TrackBack (0)

March 26, 2008

Study Examines Diaphragm Use, Acceptability for STI Prevention

Public Release Date: 20-March-2008

Abstract of "Evidence-Based Planning of a Randomized Controlled Trial on Diaphragm Use for Prevention of Sexually Transmitted Infections," Behets et al. Sexually Transmitted Diseases, March 2008.

Frieda Behets of the University of North Carolina-Chapel Hill and colleagues examined whether commercial sex workers in Madagascar would accept and use a diaphragm to prevent sexually transmitted infections in an effort to determine potential obstacles in future research on the effectiveness of a diaphragm for use in STI prevention.

Continue reading "Study Examines Diaphragm Use, Acceptability for STI Prevention"

March 26, 2008 in Barriers , Contraception , Contraceptives , Medical Access , Pharmaceutical Products , Women’s Health | Permalink | TrackBack (0)

February 13, 2008

Kroger Launches Discount Drug Program, Includes Generic Birth Control

Public Release Date: 7-February-2008

On Wednesday, the Cincinnati-based Kroger announced that it will begin selling 30-day supplies of more than 300 generic prescription drugs, including birth control pills, at significant discounts at participating pharmacies nationwide, the Atlanta Journal-Constitution reports.

Continue reading "Kroger Launches Discount Drug Program, Includes Generic Birth Control"

February 13, 2008 in Contraception , Contraceptives , News , Oral Contraceptives , Pharmaceutical Products , Women’s Health | Permalink | TrackBack (0)